Acronyms that contain the term remdesivir 

Remdesivir

Remdesivir (development code GS-5734) is a novel antiviral drug in the class of nucleotide analogs. It was developed by Gilead as a treatment for Ebola virus disease and Marburg virus infections, though it has subsequently also been found to show antiviral activity against other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus, and coronaviruses (including MERS and SARS viruses). It is being studied for 2019-nCoV and Nipah and Hendra virus infections. Based on success against other coronavirus infections, Gilead provided remdesivir to physicians that treated an American patient in Snohomish County, Washington infected with the Wuhan coronavirus, 2019-nCoV, and is providing the compound gratis, to China, to conduct a pair of trials in infected individuals with and without severe symptoms.

see more »